Introduction
Neocarzinostatin (NCS) is an antitum or protein antibiotic. For clinical grade m aterial we use in this communication the international nonproprietary name (INN) of the drug, zinostatin. It was first isolated from culture filtrates of Streptom yces carzinostaticus by Ishida [1] , The protein has a molecular weight of 10700 and consists of a single chain of 109 amino acids of known sequence [2] , It also contains an essential nonprotein chrom ophore [3, 4] .
Work from several laboratories indicates that NCS causes DNA strand breaks by degrading the backbone sugars [5 -7 ] via reactions of the chrom o phore [8] [9] [10] [11] .
Several independent investigations have shown that dissociation of the chrom ophore from protein and interaction with DNA are the first steps in NCS action [12, 13] . This dissociation process opens a new possibility for applications of NCS. The drug could be linked to monoclonal antibodies against surface antigens of tum or cells via bifunctional agents, to yield selective drug molecules [14, 15] . To accomplish such work quantities of almost a gram of biologically active NCS are necessary. Since stocks of clinical NCS appear to be exhausted Abbreviations: Apo-NCS, Neocarzinostatin free of chrom o phore and biologically inactive; FPLC, fast protein liquid chromatography; HPLC, high pressure liquid chromotography or how proteins like to be chrom otographed; NCS, Neocarzinostatin. several laboratories have turned to producing their own material [16] .
However, most purification methods for NCS described in the literature employing liquid chromatography are rather tedious and involve many steps partly under conditions, which favour the transition of NCS to biologically inactive apo-NCS by release of chrom ophore [17] [18] [19] . The separation of active NCS from apo-NCS proved to be especially difficult and lengthy in our hands.
For these reasons we have adapted HPLCtechniques to purify NCS with newly developed column material which is commercially available.
In this communication we report a fast purifica tion method for NCS from crude extracts. The activity of the drug isolated by fast protein liquid chromatography (FPLC) was measured by bio logical and physicochemical methods.
Materials and M ethods

Chromatography
A high performance liquid chrom atography system (Pharmacia FPLC) was employed for all the studies reported here. The system consists of two P-500 pumps, the gradient program m er GP-250, a fixed wavelength detector UV-1 (280 nm), and a two channel recorder REC-482 for the simultaneous recording of salt gradient and optical density. The gradient programm er was set as follows: a linear gradient of 0 -3 % B in 2.5 min, followed by 3-25% B in 11 min, and finally by 25-100% B in 2 min.
For gel filtration a Sephadex G-50 fine column (2.6 x 86 cm) equilibrated with 20 m M am m onium acetate, pH 5, was used. M aterial was eluted from that column with a flow rate of 26 m l/h.
Neocarzinostatin
Crude extracts of NCS were obtained from culture filtrates of Streptomyces carzinostaticus by using the methods described in the literature [21, 23] . Enriched crude extract was prepared by pooling biologically active fractions after gel filtra tion of crude extracts on Sephadex G 50. Clipical zinostatin which originated from Kayaku Antibiotics Inc. was a gift of the Investigational Drug Branch of the National Cancer Institute Bethesda, Md, USA. It was stored at 4°C in 15 m M sodium acetate buffer, pH 5 at a concentration o f 660 pg/ml.
All preparative steps with crude extract or zino statin were done under conditions which m inim ize the transition from NCS to apo-NCS (pH 5, temperature at 4°C , protected from daylight). For some experiments NCS was converted into apo-NCS by UV irradiation (335 nm).
NCS concentrations were determ ined by fluo rescence spectroscopy [8] and biological assay.
Quantitative N C S determination by fluorescence spectroscopy
Fluorescence spectroscopy was done with a Perkin-Elmer 650-10S spectrometer. To NCSsolutions in phosphate buffer 20 m M , pH 7.5, isopropanol was added (final concentration about 4 m ) to accelerate the dissociation of chrom ophore from NCS [8] . The released chrom ophore "decays" in aqueous solutions giving an inactive product with a distinct fluorescence at 490 nm when excited with 380 nm light. The fluorescent intensity is propor tional to the amount of inactive chrom ophore.
This gives a very fast and reproducible method for quantification of small amounts of NCS (>0.1 ng/ml).
Quantitative N C S determination by biological assay
The biological activity of NCS was determ ined by measuring the zone of inhibition of spore germination. B. subtilis spores (ATCC 6633) were plated in soft nutrient agar. Samples to be tested were applied as 10 p.1 aliquots on 6 mm paper discs. NCS concentrations as low as 3 |ig/m l could be tested. The NCS concentrations obtained from these methods agree within experimental error.
Results and Discussion
A 200 pi sample of undiluted clinical zinostatin was applied onto the Mono Q column and eluted with the described salt gradient. As can be seen from Fig. 1 a practically all UV2go-absorbing material is bound to the column. Three well separated peaks are found in the chromatogram, mobilized at 65 mM, 90 mM, and 130 mM NaCl, respectively. Each peak was collected separately and the NCS content analysed by fluorescence and by the biological test. Only the second and the third peaks contained biological activity.
A UV irradiated sample was analysed in the same way. Fig. 1 b indicates that a considerable fraction (~ 30%) is no longer bound to the Mono Q column. Furthermore peak 3 has almost disappeared while peak 4 has increased considerably. The small peak 2 is also diminished. In peak four neither a fluo rescence increase nor biological activity was found. From these results it can be concluded that peak 3 in Fig. 1 a represents active NCS while peak 4 in Fig. 1 b is apo-NCS. This was also confirmed by measuring the absorption ratio ^2 7 3 /^3 4 0 which was found to be 3.4 for peak 3 and 27 for peak 4. Next 0.5 ml of crude extract was loaded onto the Mono Q column and eluted whith the salt gradient. Biological activity was found at 90 mM NaCl. This material was diluted with salt-free buffer and rechromatographed, giving a single peak at 90 mM NaCl (Fig. 2) .
Enriched crude extract was also chrom atographed on the Mono Q column and the elution profile is seen in Fig. 3 . O f the seven peaks collected separately the material eluting at 90 mM NaCl showed fluorescence increase and biological activity. The absorption ratio A iyi/A m for this peak was 3.3, a value usually found for native NCS. Upon rechromatography o f peak 4 the pattern in Fig. 4 was obtained. By com parison with the NCS peak of Fig. 1 a it can be judged that clinical grade NCS is obtained from enriched crude extract on a Mono Q column with within 20 min.
Separations were found to be very reproducible from run to run. Recovery of zinostatin activity was usually about 70%.
Conclusions
Fast protein liquid chrom atography on the Mono Q anion exchange column has been success fully applied for isolation of the antitum or protein neocarzinostatin from crude extracts. The purity of the resulting preparations is com parable to that of clinical zinostatin, as can be judged from O. D. measurements and biological activity. The separa tion of zinostatin from apo-NCS and other con taminating impurities was achieved at low pH (5.0) and under conditions where zinostatin re mains stable. Allowing 5 min for washing and equilibrating of the Mono Q column a run can be repeated after 20 min. This compares favourably with the long separation time (up to 60 h) necessary using conventional methods [18] , The high capacity of the column (25 mg protein) and a recovery of up to 70% as well the speed and reproducibility of the separations make the described system suitable for large scale preparative work.
